medigraphic.com
ISSN 1729-6935 (Electronic)
16 de abril

2020, Number 278

<< Back Next >>

16 de abril 2020; 59 (278)

Hyperviscosity syndrome: pathophysiological and clinical characteristics

Blanco SY, Areces LA, Gámez PA

Language: Spanish
References: 33
Page: 1-5
PDF size: 217.75 Kb.


ABSTRACT

Introduction: Hyperviscosity syndrome can manifest itself in various hematological diseases. Objective: to describe the main pathophysiological and clinical characteristics of hyperviscosity syndrome. Material and methods: scientific texts and articles published in scientific journals were consulted, for a total of 33 bibliographic references, most of them less than 5 years old. Development: the increase in blood viscosity in the context of some hematological diseases, such as monoclonal gammopathies and polycythemia, is a complication that can manifest clinically with circulatory disorders and repercussions in various systems of the economy. In its treatment three procedures are proposed: plasmapheresis, blood transfusions and the specific treatment of the underlying disease. Conclusions: identifying the presence of a hyperviscosity syndrome guarantees a more effective therapeutic approach for the clinical entities that produce it.


REFERENCES

  1. Martell-Martorell L, Arencibia-Núñez A. Infecciones intrahospitalarias en pacientes pediátricos con enfermedades hematológicas, 2006-2009. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2012 Sep [citado 11 Dic 2017]; 28(3): 253-262. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892012000300007&lng=es.

  2. Pizzo PA. Fever in immunocompromised patients. N Engl J Med. 2015; 341 (22): 893-900.

  3. Vusirikala M. Supportive care in hematologic malignancies. En: Greer JP, Lukens JN, editors. Wintrobe’s Clinical Hematology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2016.

  4. Esquijarosa Roque BM, Guillén Cánovas AM, Álvarez Reinoso S, Bazabe Márquez MI, Hernández García J. Enfermedades hematológicas graves en la unidad de cuidados intensivos pediátricos pinareña. Rev Ciencias Médicas [Internet]. 2017 Ago [citado 11 Dic 2017]; 21 (4): 48-55. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942017000400008&lng=es.

  5. Castelló González M, Delgado Marín N, Pla del Toro MJ, Hernández Moore E. Esplenectomía por enfermedades hematológicas en la infancia. AMC [Internet]. 2012 Oct [citado 11 Dic 2017]; 16 (5): 579-590. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552012000500007&lng=es.

  6. Bladé Creixentí J, Bosch Albareda F, Campo Güerri E, Carreras Pons E. Hematología. En: Medicina Interna. Vol 1. 17ª ed. España: Elsevier; 2014. p.1564.

  7. Roca Goderich R. Discrasias de células plasmáticas. En: Temas de Medicina Interna. Vol 3. 4ª ed. La Habana: ECIMED; 2015. p. 51.

  8. Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC (July 2014). «Multiple myeloma». Lancet 374 (9686): 324–39.

  9. Gómez E, Roncero C, De Pablo J, Rovira M. Síndrome de hiperviscosidad y alteraciones mentales. Acta Esp Psiquiatr. 2015; 28(4):263-6.

  10. Foerster J. Discrasias de células plasmáticas: consideraciones generales. Hematología Clínica de Wintrobe. 9na. ed. Buenos Aires: Editorial Intermédica; 2015. pp. 1909-23.

  11. Seth R, Bhat AS. Management of Common Oncologic Emergencies. Indian J Pediatr. 2015 Mar 12. [Epub ahead of print] DOI 10.1007/s12098-011-0381-5.

  12. Stone M, Bogen S. Evidence-based focused review of management of hyperviscosity syndrome. Blood 2015; 119: 2205-08.

  13. Kwaan H, Bongu A. The hyperviscosity syndromes. Semin Thromb Hemost 1999; 25:199-204.

  14. Joles JA, Willekes-Koolschijn N, Koomans HA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int 2014; 52:761-70.

  15. Lane D, L’Anson S. Viscosimetric effect of fibrinogen. J Clin Pathol 2014; 47:1004-5.

  16. Ramón Rodríguez LG, Avila Cabrera O, Izquierdo Cano L, Espinosa Estrada E, González Pinedo L, Quintero Sierra Y et al. Síndrome de hiperviscosidad en pacientes con mieloma múltiple. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2013 Sep [citado 13 Nov 2017]; 29(3): 259-271. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892013000300006&lng=es.

  17. Bladé Creixentí J, Bosch Albareda F, Campo Güerri E, Carreras Pons E. Gammapatías monoclonales. En: Medicina Interna. Vol 1. 17ª ed. España: Elsevier; 2015. p.1626.

  18. Cooke B, Stuart J. Automated measurement of plasma viscosity by capillary viscometer. J Clin Pathol 2015; 41: 1213-16.

  19. Bloch HS. Serum protein changes in Waldenström macroglobulinaemia during administration of a low molecular weight thiol (Penicilamine). J Lab Clin Med 2015; 56: 212-15.

  20. Capra J. Kunkel H. Aggregation of G3 protein: Relevance to the hyperviscosity syndrome. J Clin Inves 1970; 49: 610-15.

  21. Wright DJ. Jenkins DE. Simplified method of stimulation of serum and plasma viscosity in multiple myeloma and related disorders. Blood 2014; 36: 516.

  22. Foerster J. Discrasias de células plasmáticas: consideraciones generales. Hematología Clínica de Wintrobe. 9na ed. Argentina: Editorial Intermédica; 1995; p. 1909-23.

  23. Kyle R, Rajkumar S. Multiple Myeloma. N Engl J Med 2015; 18:1860-73.

  24. Kyle R, Gertz M, Witzig T, Lust J, Lacy M, Dispenzieri A, et al. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma. Mayo Clin Proc 2015; 78:21-33.

  25. Blum W, Porcu P. Therapeutic Apheresis in Hyperleukocytosis and Hyperviscosity Syndrome. Semin Thromb Hemost 2014; 33: 350-54.

  26. Ramón L, Hernández CR, Buchillón RJ, Palsencia A, Agramonte O, Hernández P. Empleo de la Talidomida en un paciente con mieloma múltiple refractario. Rev Cubana Hematol Inmunol Hemoter [online]. 2015, vol.18, n.3, pp. 61-63.

  27. McCullogh J. Therapeutic apheresis In: McCullogh J. (Ed.) Transfusion Medicine. Philadelphia: Elsevier Churchill Livingstone, 2015; p. 517-47.

  28. Zarkovic M, Kwaan H. Correction of hyperviscosity by apheresis. Sem Thromb Hemost 2014; 29:535-42.

  29. Ballestri M, Ferrari F, Magistrom R, Mariano M. Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guideline study. Ann Inst Super Sanitá 2014; 43: 171-75.

  30. Galel S, Nguyen D, Fontaine M, Goodnough, Viele M. Transfusion Medicine. Greer J, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber D, Means RT, eds. Wintrobe’s Clinical hematology. 12th Edition, Lippincott Williams & Wilkins. Philadelphia. 2014, p673-711.

  31. Halfdanarson T, Hogan W, Moyhan T. Oncology Emergencies. Mayo Clin Proc 2015; 81: 835-48.

  32. Zojan N, Ludwig H. Hematological Emergencies. Ann Oncol 2007; 18: 145-48.

  33. Lewis M, Hendrickson A, Moynihan T. Oncologic Emergencies: Pathophysiology, Presentation, Diagnosis, and Treatment. CA Cancer J Clin 2014; 61:287-14.




2020     |     www.medigraphic.com